跳至主要内容
临床试验/NCT03357887
NCT03357887已完成不适用

Prognostic Value of Three New Biomarkers of Multiple Sclerosis Compared to Reference Biomarker in Patients With Radiologically Isolated Syndrome

Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
Level of Neurofilament in cerebrospinal fluid

研究概览

简要总结

To look at the prognostic value of new biomarkers in CSF and serum for characterisation of multiple sclerosis

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Level of Neurofilament in cerebrospinal fluid

时间窗: Baseline

ELISA

Level of GFAP in cerebrospinal fluid

时间窗: Baseline

ELISA

Level of tumour necrosis factor receptor in cerebrospinal fluid

时间窗: Baseline

ELISA

Level of secreted glycoprotein in cerebrospinal fluid

时间窗: Baseline

ELISA

次要结局

  • Level of GFAP in serum(Baseline)
  • Level of Neurofilament in serum(Baseline)
  • Level of secreted glycoprotein in serum(Baseline)
  • Compare prognostic value of all four markers of the high risk criteria (age below 37, male, myelitis).(Baseline)
  • Biomarker levels in CSF and serum in different patient subpopulations (Radiologically Isolated Syndrome, recurrent remittent MS, symptomatic controls, central nervous system inflammatory disease controls, non-inflammatory disease controls)(Baseline)
  • Level of tumour necrosis factor receptor in serum(Baseline)
  • Comparison of the conversion time according to the threshold value of each biomarker for Radiologically Isolated Syndrome patients(Baseline)

研究者

发起方
Centre Hospitalier Universitaire de Nīmes
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验